Related references
Note: Only part of the references are listed.Loss of Angiotensin-Converting Enzyme-2 Exacerbates Diabetic Cardiovascular Complications and Leads to Systolic and Vascular Dysfunction A Critical Role of the Angiotensin II/AT1 Receptor Axis
Vaibhav B. Patel et al.
CIRCULATION RESEARCH (2012)
Role of ACE2 in diastolic and systolic heart failure
Wang Wang et al.
HEART FAILURE REVIEWS (2012)
Cardioprotective Effects Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin 1-7 in Experimental Heart Failure in Angiotensin-Converting Enzyme 2-Null Mice
Vaibhav B. Patel et al.
HYPERTENSION (2012)
Renal sympathetic activation from long-term low-dose angiotensin II infusion in rabbits
John-Luis Moretti et al.
JOURNAL OF HYPERTENSION (2012)
Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47phox NADPH oxidase subunit
Sreedhar Bodiga et al.
CARDIOVASCULAR RESEARCH (2011)
Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases
Anderson J. Ferreira et al.
EXPERIMENTAL PHYSIOLOGY (2011)
Prevention of Angiotensin II-Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2
JiuChang Zhong et al.
HYPERTENSION (2011)
Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1-7) in heart and kidney of spontaneously hypertensive rats
Zhen Tan et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2011)
Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression
Jiu-Chang Zhong et al.
REGULATORY PEPTIDES (2011)
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors
S. Wind et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
JiuChang Zhong et al.
CIRCULATION (2010)
Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
Gavin Y. Oudit et al.
DIABETES (2010)
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2 Prevention of Angiotensin II-Dependent Hypertension
Jan Wysocki et al.
HYPERTENSION (2010)
Angiotensin-(1-7) Prevents Cardiomyocyte Pathological Remodeling Through a Nitric Oxide/Guanosine 3 ',5 '-Cyclic Monophosphate-Dependent Pathway
Eneas R. M. Gomes et al.
HYPERTENSION (2010)
Onset of Experimental Severe Cardiac Fibrosis Is Mediated by Overexpression of Angiotensin-Converting Enzyme 2
Rachel Masson et al.
HYPERTENSION (2009)
Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical Outcomes
Slava Epelman et al.
JOURNAL OF CARDIAC FAILURE (2009)
Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway
Vijay Koka et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts - Implication for the therapeutic effect of statin in atrial structural remodeling
Chia-Ti Tsai et al.
CIRCULATION (2008)
Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation
Yumei Feng et al.
CIRCULATION RESEARCH (2008)
Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
Chantal Mercure et al.
CIRCULATION RESEARCH (2008)
Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents
Jose A. Hernandez Prada et al.
HYPERTENSION (2008)
Detection of soluble angiotensin-converting enzyme 2 in heart failure
Slava Epelman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease
Jan Monti et al.
NATURE GENETICS (2008)
Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells
Walkyria O. Sampaio et al.
HYPERTENSION (2007)
ACE2: A new target for cardiovascular disease therapeutics
Mohan K. Raizada et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats
Masanobu Yamazato et al.
HYPERTENSION (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR
Carlos Diez-Freire et al.
PHYSIOLOGICAL GENOMICS (2006)
Increased NADPH oxidase activity mediates spontaneous aortic tone in genetically hypertensive rats
Federica Lodi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis
Gavin Y. Oudit et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
ACE2: A novel therapeutic target for cardiovascular diseases
S Der Sarkissian et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2006)
Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME
IF Benter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
NADPH oxidases in the kidney
Pritmohinder S. Gill et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor
EA Tallant et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
CM Ferrario et al.
CIRCULATION (2005)
Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension
MJ Katovich et al.
EXPERIMENTAL PHYSIOLOGY (2005)
Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats
MJ Huentelman et al.
EXPERIMENTAL PHYSIOLOGY (2005)
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors
Y Ishiyama et al.
HYPERTENSION (2004)
Oxidative stress and cardiovascular injury - Part I: Basic mechanisms and in vivo monitoring of ROS
KK Griendling et al.
CIRCULATION (2003)
Angiotensin-converting enzyme 2 is an essential regulator of heart function
MA Crackower et al.
NATURE (2002)
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase
C Vickers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
New concepts in diastolic dysfunction and diastolic heart failure: Part II - Causal mechanisms and treatment
MR Zile et al.
CIRCULATION (2002)
Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney
T Chabrashvili et al.
HYPERTENSION (2002)
A human homolog of angiotensin-converting enzyme - Cloning and functional expression as a captopril-insensitive carboxypeptidase
SR Tipnis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
NAD(P)H oxidase - Role in cardiovascular biology and disease
KK Griendling et al.
CIRCULATION RESEARCH (2000)
Essential hypertension Part I: Definition and etiology
OA Carretero et al.
CIRCULATION (2000)
Share Paper
